TherapeuticsMD (TXMD) Shares Outstanding (Diluted Average) (2022 - 2025)

TherapeuticsMD has reported Shares Outstanding (Diluted Average) for 4 years, with the latest figure at $11.6 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) changed 0.32% year-over-year to $11.6 million; the trailing twelve-month figure through Dec 2025 stood at $11.6 million (changed 0.32% YoY), and the FY2025 full-year result was $11.6 million, changed 0.32% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2025 stood at $11.6 million, roughly flat from $11.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $11.6 million in Q2 2025, with the low at $10441.0 in Q4 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $9.9 million across 4 years, with a median of $10.9 million in 2023.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) tumbled 99.89% — and 2024, when it surged 110349.19%.
• TherapeuticsMD's Shares Outstanding (Diluted Average) stood at $9.4 million in 2022, then plunged by 99.89% to $10441.0 in 2023, then surged by 110349.19% to $11.5 million in 2024, then increased by 0.32% to $11.6 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $11.6 million (Q4 2025), $11.6 million (Q3 2025), and $11.6 million (Q2 2025), per Business Quant data.